For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Year 1 M / Year 2 M | Following a blinded transition from year one- Methotrexate dose consistent with the ending dose of year one (usually 20 mgs). No reduction of MTX dose is permitted in year two. | None | None | 12 | None | 79 | None | View |
| Year 1 M+Placebo | Oral Methotrexate capsules once weekly + two injections of placebo given at the same time at different sites. MTX dose is a forced titration from 7.5mg (3 capsules) to 20 mg weekly (8 capsules) by week 8. | None | None | 34 | None | 241 | None | View |
| Year 1 E+M / Year 2 E+M | Following a blinded transition from year one- Etanercept injection- two injections 25 mg weekly (given at the same time at different sites)+ oral Methotrexate capsules weekly (same day as injection). Dose consistent with the ending dose at year one (usually 20 mgs). No reduction of MTX dose is permitted in year two. | None | None | 8 | None | 91 | None | View |
| Year 1 E+M / Year 2 E | Following a blinded transition from year one-Etanercept two injections 25 mg weekly (given at the same time at different sites). | None | None | 10 | None | 89 | None | View |
| Year 1 E+M | Etanercept injection- two injections 25 mg weekly (given at the same time at different sites) + oral Methotrexate capsules weekly (same day as injection). MTX dose is a forced titration from 7.5mg (3 capsules) to 20 mg weekly (8 capsules) by week 8. | None | None | 33 | None | 246 | None | View |
| Year 1 M / Year 2 E+M | Following a blinded transition from year one- Etanercept two injections 25 mg weekly (given at the same time at different sites) + oral Methotrexate capsules weekly (same day as injection). Dose consistent with the ending dose at year one (usually 20 mgs). No reduction of MTX dose is permitted in year two. | None | None | 11 | None | 71 | None | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Intervertebral disc disorder | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Ischaemia | NON_SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Angina unstable | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Arrhythmia | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Aterial fibrillation | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Myocardial infarction | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Pericarditis | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Ventricular tachycardia | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Vertigo | NON_SYSTEMATIC_ASSESSMENT | Ear and labyrinth disorders | None | View |
| Photophobia | NON_SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Appendicitis perforated | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Gastritis | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| General gastrointestinal disorder | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Gastrointestinal haemorrhage | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Mechanical ileus | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Vomiting | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Chest pain | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| General physical health deterioration | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Cholelithiasis | NON_SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | None | View |
| Gallbladder disorder | NON_SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | None | View |
| Acute sinusitis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Bronchitis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Chronic sinusitis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Diverticulitis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Gastroenteritis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Herpes zoster | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Lung infection | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Lyme disease | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Nasopharyngitis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Pneumonia | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Septic athritis staphylococcal | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Skin infection | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Streptococcal infection | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Accidental overdose | NON_SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Joint injury | NON_SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Overdose | NON_SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Pelvic fracture | NON_SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Procedural pain | NON_SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Radius fracture | NON_SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Spinal fracture | NON_SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Blood alkaline phosphatase increased | NON_SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Hepatic enzyme increased | NON_SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Transaminases increased | NON_SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Diabetes mellitus | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Hyponatraemia | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Arthritis | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Haemarthrosis | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Intervetebral disc protrusion | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Osteoarthritis | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Rheumatoid arthritis | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Basal cell carcinoma | NON_SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | None | View |
| Bowen's disease | NON_SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | None | View |
| Breast cancer | NON_SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | None | View |
| Chronic lymphocytic leukamia | NON_SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | None | View |
| Prostate cancer | NON_SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | None | View |
| Tongue neoplasm | NON_SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | None | View |
| Cerebral haemorrhage | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Headache | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Paraesthesia | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Syncope | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Syncope vasovagal | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Anxiety | NON_SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Sleep disorder | NON_SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Renal failure | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Urinary retention | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Idiopathic pulmonary fibrosis | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Interstitial lung disease | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Pneumonitis | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Pneumothorax | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Hyperhidrosis | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Hip arthroplasty | NON_SYSTEMATIC_ASSESSMENT | Surgical and medical procedures | None | View |
| Hospitalisation | NON_SYSTEMATIC_ASSESSMENT | Surgical and medical procedures | None | View |
| Deep vein thrombosis | NON_SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Infarction | NON_SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Aortic valve stenosis | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Atrio ventricular block | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Mitral valve incompetence | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Abdominal pain upper | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Inguinal hernia | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Systemic inflammatory response system | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Bursitis infected staphylococcal | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Pneumonia streptococcal | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Tonsillitis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Concussion | NON_SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Device failure | NON_SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Fall | NON_SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Ligament injury | NON_SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Skull fractured base | NON_SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Arthropathy | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Spondylolisthesis acquired | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Gastrointestinal carcinoma | NON_SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | None | View |
| Lung cancer metastatic | NON_SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | None | View |
| Malignant melanoma of sights other than skin | NON_SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | None | View |
| Metastases to lung | NON_SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | None | View |
| Pancreatic carcinoma | NON_SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | None | View |
| Transitional cell carcinoma | NON_SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | None | View |
| Cerebellar infarction | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Cerebral infarction | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Cerebrovascular accident | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Hydrocephalus | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Sciatica | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Confusional state | NON_SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Renal and urinary disorders | NON_SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Renal colic | NON_SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Testicular torsion | NON_SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | None | View |
| Vaginal prolapse | NON_SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | None | View |
| Dyspnoea | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Pulmonary embolism | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Cholecystectomy | NON_SYSTEMATIC_ASSESSMENT | Surgical and medical procedures | None | View |
| Haemorrhoid operation | NON_SYSTEMATIC_ASSESSMENT | Surgical and medical procedures | None | View |
| Aneurysm | NON_SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Blood and lymphatic | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Cardiac disorders | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Ear and labyrinth | NON_SYSTEMATIC_ASSESSMENT | Ear and labyrinth disorders | None | View |
| Eye | NON_SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Abdominal pain upper | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Diarhhea | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Nausea | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Vomiting | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Administration site conditions | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Nasopharyngitis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Upper respiratory tract infections | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Urinary tract infections | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Post procedural nausea | NON_SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Investigations | NON_SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Rheumatoid arthritis | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Headache | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Psychiatric | NON_SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Renal and urinary | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Cough | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Alopecia | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Rash | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Hypertension | NON_SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Dyspepsia | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Infections and Infestations | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Gastroenteritis | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Lower respiratory tract infection | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Rhinitis | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Injury, poisoning and procedural complications | NON_SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Alanine aminotransferase increased | NON_SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Back pain | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Neoplasms benign | NON_SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | None | View |
| Depression | NON_SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |